Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.

NCT02417844 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients

NCT02244229 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

NCT02244268 ·Status: COMPLETED

Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms

NCT02715024 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia

NCT02033798 ·Status: UNKNOWN ·Phase: NA

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

NCT00090103 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

NCT02244242 ·Status: COMPLETED ·Phase: PHASE4

Actual Use Study of Tamsulosin in Men

NCT02573311 ·Status: COMPLETED ·Phase: PHASE3

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms

NCT01018511 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Effect of Paroxetine Mediated CYP2D6 Inhibition on the Pharmacokinetics of Tamsulosin in Healthy Male Volunteers

NCT02264184 ·Status: COMPLETED ·Phase: PHASE1

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

NCT02417831 ·Status: COMPLETED ·Phase: PHASE1

(Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia

NCT05236634 ·Status: UNKNOWN ·Phase: NA

A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.

NCT00379067 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study

NCT06809205 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

NCT05422677 ·Status: COMPLETED

Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis

NCT00913315 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia

NCT02827578 ·Status: UNKNOWN ·Phase: PHASE3

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH

NCT00510406 ·Status: COMPLETED ·Phase: PHASE2

Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms

NCT01021332 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional Formulation

NCT02180789 ·Status: COMPLETED ·Phase: PHASE4

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia

NCT00701779 ·Status: COMPLETED ·Phase: PHASE4

Composite Steep-pulseTreatment Device Used in Patients With Benign Prostatic Hyperplasia

NCT05531344 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.

NCT05401032 ·Status: RECRUITING ·Phase: PHASE2

Clinical Effect and Safety of Tamsulosin 0.4mg in Patients With LUTS/BPH Refractory to Tamsulosin 0.2mg

NCT00954889 ·Status: UNKNOWN ·Phase: NA

A Study in Benign Prostatic Hyperplasia

NCT01152190 ·Status: COMPLETED ·Phase: PHASE3